Coagulants and Anti-Coagulants
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
EPTIFIBATIDE: products 1 to 6 of 6.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Eptifibatide Injection 0.75mg/mL 100mL Vial PkDIN 02405083 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Eptifibatide Injection 0.75mg/mL 100mL Vial PkDIN 02540819 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Eptifibatide Injection 2mg/mL 10mL Vial PkDIN 02367858 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Eptifibatide Injection 2mg/mL 10mL Vial PkDIN 02540827 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Integrilin 0.75mg/mL 100mL Vial PkDIN 02240351 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Integrilin 2mg/mL 10mL Vial PkDIN 02240352 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
20:12 Coagulants and Anti-Coagulants.
20:12:04 Direct Factor Xa Inhibitors.
20:12:16 Hemostatics.